Position in GRFS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$38,628
-$16,798 QoQ
Shares Held
5,456
-8.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#114
of 164 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mirae Asset Global Investments Co., Ltd. holds $1,549,695,317 across 14 Drug Manufacturers - General names. GRFS ranks #14 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
286,254 | $343,341,662 | |
| 2 | AMGN |
Amgen Inc
|
785,516 | $284,451,053 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,033,072 | $261,249,751 | |
| 4 | JNJ |
Johnson & Johnson
|
718,900 | $182,579,032 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
2,396,422 | $138,081,835 | |
| 6 | ABBV |
AbbVie Inc.
|
495,003 | $124,562,554 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
926,242 | $117,021,414 | |
| 8 | PFE |
Pfizer Inc
|
1,539,905 | $37,080,912 |
All Filings in GRFS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,628 | 5,456 | Shares | Sole | 2026-07-22 | |
| 2025-12-31 | $55,426 | 5,928 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $46,971 | 4,716 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $42,605 | 4,713 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $28,240 | 3,972 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $30,243 | 4,065 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $39,178 | 4,412 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $22,981 | 3,642 | Shares | Sole | 2024-07-30 | |
| No filing history on record for this holder in this stock. | ||||||